SLC2A1 and cancer: In most types of human cancer cells, active PI3K–Akt signaling acts as a crucial coordinator of glycolytic and lipid metabolism to conduct the metabolic reprogramming of cancer cells by regulating the glucose transporter-1 (GLUT-1)-mediated glucose uptake [85,86].